Affymetrix Posts Increase in Q1 Revenues, but Expects Future Losses Due to Mouse Arrays | GenomeWeb

NEW YORK, April 25 – Affymetrix reported a 36 percent increase in first-quarter revenues Wednesday, but said it expected to lose $15 to $25 million in revenues for the year due to its defective mouse arrays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.